Anacor Pharmaceuticals Reaches New 12-Month High at $23.09 (ANAC)
Anacor Pharmaceuticals (NASDAQ:ANAC)’s share price hit a new 52-week high during mid-day trading on Thursday , AR Network reports. The company traded as high as $23.09 and last traded at $22.63, with a volume of 340,955 shares. The stock had previously closed at $22.56.
Separately, analysts at Jefferies Group raised their price target on shares of Anacor Pharmaceuticals from $24.00 to $25.00 in a research note on Friday, August 8th. They now have a “buy” rating on the stock. One analyst has rated the stock with a hold rating and three have given a buy rating to the company. Anacor Pharmaceuticals has an average rating of “Buy” and an average price target of $24.50.
The stock’s 50-day moving average is $18.32 and its 200-day moving average is $17.72. The company has a market cap of $956.2 million and a P/E ratio of 14.05.
Anacor Pharmaceuticals (NASDAQ:ANAC) last announced its earnings results on Thursday, August 7th. The company reported ($0.58) earnings per share for the quarter, beating the analysts’ consensus estimate of ($0.63) by $0.05. The company had revenue of $2.90 million for the quarter, compared to the consensus estimate of $3.03 million. During the same quarter last year, the company posted ($0.36) earnings per share. Anacor Pharmaceuticals’s revenue was down 14.7% compared to the same quarter last year. Analysts expect that Anacor Pharmaceuticals will post $-2.39 EPS for the current fiscal year.
Anacor Pharmaceuticals Inc is a United States-based biopharmaceutical company focused on discovering, developing and commercializing small-molecule therapeutics derived from its boron chemistry platform.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.